Search by Drug Name or NDC
NDC 46122-0583-74 Maximum Strength Mucus Relief 1200 mg/1 Details
Maximum Strength Mucus Relief 1200 mg/1
Maximum Strength Mucus Relief is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Amerisource Bergen. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 46122-0583-74Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 46122-0583 |
---|---|
Product ID | 46122-583_530c8ce6-676d-4a98-b9c1-5cf6f67abf9d |
Associated GPIs | 43200010007450 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Maximum Strength Mucus Relief |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 1200 |
Active Ingredient Units | mg/1 |
Substance Name | GUAIFENESIN |
Labeler Name | Amerisource Bergen |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209215 |
Listing Certified Through | 2023-12-31 |
Package
Package Images

NDC 46122-0583-74 (46122058374)
NDC Package Code | 46122-583-74 |
---|---|
Billing NDC | 46122058374 |
Package | 2 BLISTER PACK in 1 CARTON (46122-583-74) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Marketing Start Date | 2019-11-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 8679de8f-a4cb-4dc6-9fac-f8e378dba3f9 Details
USE(S)
ASK A DOCTOR BEFORE USE IF YOU HAVE
STOP USE AND ASK A DOCTOR IF
KEEP OUT OF REACH OF CHILDREN
DIRECTIONS
OTHER INFORMATION
QUESTIONS?
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
MAXIMUM STRENGTH MUCUS RELIEF
guaifenesin tablet, extended release |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Amerisource Bergen (007914906) |
Revised: 1/2022
Document Id: 530c8ce6-676d-4a98-b9c1-5cf6f67abf9d
Set id: 8679de8f-a4cb-4dc6-9fac-f8e378dba3f9
Version: 3
Effective Time: 20220111